Skip to main content
Clinical Trials/NCT01330433
NCT01330433
Completed
Phase 2

Effects of CoSeal in Reducing Perioperative Bleeding & Adhesions in Pediatric Heart Surgery

Loma Linda University1 site in 1 country35 target enrollmentAugust 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Congenital Heart Defect
Sponsor
Loma Linda University
Enrollment
35
Locations
1
Primary Endpoint
Severity of Adhesions at the Retrosternal Site
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This is a prospective, randomized, open-label, blinded-evaluator study that will evaluate the effectiveness of a surgical sealant (CoSeal) composed of biocompatible polyethylene glycol on the formation of mediastinal and pericardial adhesions in children undergoing staged surgical reconstruction (potential procedures include: Blalock-Taussig Type Operation, Classical Glenn Procedure, Bidirectional Glenn Procedure, Norwood). Additionally, bleeding will be evaluated by drainage post-operatively through surgical site drainage output.

Registry
clinicaltrials.gov
Start Date
August 2011
End Date
August 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nahidh Hasaniya

Associate Professor

Loma Linda University

Eligibility Criteria

Inclusion Criteria

  • Have an acceptable surrogate capable of giving consent on the subject's behalf.
  • Pediatric patients ages 0 - 17
  • Have a cardiac disease which requires staged cardiac surgery and resternotomy
  • Non-emergent state or emergent state with sufficient time to educate and consent

Exclusion Criteria

  • An immune system disorder
  • Unplanned reoperation
  • Known hypersensitivity to components in CoSeal
  • Patients undergoing reoperation less than 3 months after the primary surgery

Outcomes

Primary Outcomes

Severity of Adhesions at the Retrosternal Site

Time Frame: Severity of adhesions data will be collected during approximately the first 30-60 minutes of the second staged surgery

Severity of adhesions at seven predefined sites (pericardial or retrosternal, inferior or diaphragmatic region, right lateral or arterial region, region around great vessels). Severity of adhesions is graded as 0 = no adhesions, 1 = filmy and avascular, 2 = requiring blunt dissection, 3 = requiring sharp dissection, 4 = requiring extensive sharp dissection. Adhesion scores for each patient will be derived from the sum of adhesion severity scores at each site, from 0 (no adhesions) to 28 (cohesive adhesions at all sites).

Severity of Adhesions at the Diaphragm Site

Time Frame: Severity of adhesions data will be collected during approximately the first 30-60 minutes of the second staged surgery

Severity of adhesions at five predefined sites (retrosternal, diaphragmatic region, right lateral, left lateral, arterial base). Severity of adhesions is graded as 0 = no adhesions, 1 = filmy and avascular, 2 = requiring blunt dissection, 3 = requiring sharp dissection, 4 = requiring extensive sharp dissection. Adhesion scores for each patient will be derived from the sum of adhesion severity scores at each site, from 0 (no adhesions) to 28 (cohesive adhesions at all sites).

Post-operative Bleeding

Time Frame: Post-operative bleeding data will be collected on average, during the first 36 hours after the surgery

Post-operative bleeding through surgical site drainage output.

Adhesion Burden

Time Frame: Time it takes for patient to be put on bypass (an average time between 0 and 120 minutes)

Skin to bypass time as an indicator of adhesion burden.

Severity of Adhesions at the Arterial Base Site.

Time Frame: Severity of adhesions data will be collected during approximately the first 30-60 minutes of the second staged surgery

Severity of adhesions at five predefined sites (retrosternal, diaphragmatic region, right lateral, left lateral, arterial base). Severity of adhesions is graded as 0 = no adhesions, 1 = filmy and avascular, 2 = requiring blunt dissection, 3 = requiring sharp dissection, 4 = requiring extensive sharp dissection. Adhesion scores for each patient will be derived from the sum of adhesion severity scores at each site, from 0 (no adhesions) to 28 (cohesive adhesions at all sites).

Severity of Adhesions at the Left Lateral Site

Time Frame: Severity of adhesions data will be collected during approximately the first 30-60 minutes of the second staged surgery

Severity of adhesions at five predefined sites (retrosternal, diaphragmatic region, right lateral, left lateral, arterial base). Severity of adhesions is graded as 0 = no adhesions, 1 = filmy and avascular, 2 = requiring blunt dissection, 3 = requiring sharp dissection, 4 = requiring extensive sharp dissection. Adhesion scores for each patient will be derived from the sum of adhesion severity scores at each site, from 0 (no adhesions) to 28 (cohesive adhesions at all sites).

Severity of Adhesions at the Right Lateral Site

Time Frame: Severity of adhesions data will be collected during approximately the first 30-60 minutes of the second staged surgery

Severity of adhesions at five predefined sites (retrosternal, diaphragmatic region, right lateral, left lateral, arterial base). Severity of adhesions is graded as 0 = no adhesions, 1 = filmy and avascular, 2 = requiring blunt dissection, 3 = requiring sharp dissection, 4 = requiring extensive sharp dissection. Adhesion scores for each patient will be derived from the sum of adhesion severity scores at each site, from 0 (no adhesions) to 28 (cohesive adhesions at all sites).

Secondary Outcomes

  • Hospital Stay(Length of stay after second surgery up to 1 month)

Study Sites (1)

Loading locations...

Similar Trials